Evidence map›Paper›PMID 38655992›Full record

ArticleRevista da Associacao Medica Brasileira (1992)2024

Effect of Laurus nobilis on bacteria and human transforming growth factor-β1.

Okan Sancer, Uğur Şahin, Emel Sesli Çetin, Muhammet Yusuf Tepebaşi, Yasemin Cezaroğlu, Göksel Bilir, Sibel Yünlü, Ahmet Koca

Open access · diamondAbstract read
In one paragraph

Article in Revista da Associacao Medica Brasileira (1992), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Okan SancerSuleyman Demirel University, Faculty of Medicine, Department of Medical Biology - Isparta, Turkey.ORCID http://orcid.org/0000-0001-7935-5004
Uğur ŞahinSuleyman Demirel University, Innovative Technologies Application and Research Center, Genetic Research Unit - Isparta, Turkey.ORCID http://orcid.org/0000-0002-5629-3485
Emel Sesli ÇetinSuleyman Demirel University, Faculty of Medicine, Department of Medical Microbiology - Isparta, Turkey.ORCID http://orcid.org/0000-0001-5231-3824
Muhammet Yusuf TepebaşiSuleyman Demirel University, Faculty of Medicine, Department of Medical Genetic - Isparta, Turkey.ORCID http://orcid.org/0000-0002-1087-4874
Yasemin CezaroğluSuleyman Demirel University, Faculty of Medicine, Department of Medical Microbiology - Isparta, Turkey.ORCID http://orcid.org/0000-0001-6433-3726
Göksel BilirSuleyman Demirel University, Faculty of Medicine, Department of Medical Microbiology - Isparta, Turkey.ORCID http://orcid.org/0000-0002-0375-4188
Sibel YünlüSuleyman Demirel University, Innovative Technologies Application and Research Center, Genetic Research Unit - Isparta, Turkey.ORCID http://orcid.org/0000-0003-0855-3542
Ahmet KocaIsparta University of Applied Sciences, Sütçüler Prof. Dr. Hasan Gürbüz Vocational School - Isparta, Turkey.ORCID http://orcid.org/0000-0002-9567-6542
Süleyman Demirel University · TRIsparta University of Applied Sciences · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIn this study, we aimed to determine the phenolic compounds, the antibacterial activity of extract from Laurus nobilis leaves, and its possible effect on transforming growth factor-β1 expression level in peripheral blood mononuclear cells.

methodsThe phenolic components of Laurus nobilis were identified by the high-performance liquid chromatography method. The antibacterial activity of this extract was determined by disk diffusion and broth microdilution methods. The transforming growth factor-β1 expression was analyzed using the RT-qPCR method.

resultsEpicatechin was found in the highest amount and o-coumaric acid in the lowest amount. The half-maximal inhibitory concentration (IC50) was determined to be 55.17 μg/mL. The zones of inhibition and minimum inhibitory concentration for Staphylococcus aureus, Enterococcus faecalis, and Klebsiella pneumoniae were 15, 14, and 8 mm and 125, 250, and 1000 μg/mL, respectively. The change in transforming growth factor-β1 expression levels was found to be statistically significant compared with the control groups (p<0.0001).

conclusionLaurus nobilis extract was found to be effective against bacteria and altered the expression level of transforming growth factor-β1 in peripheral blood mononuclear cells.

Indexed as

Anti-Bacterial AgentsEnterococcus faecalisLaurusLeukocytes, MononuclearMicrobial Sensitivity TestsPlant ExtractsStaphylococcus aureusTransforming Growth Factor beta1Chromatography, High Pressure LiquidHumansInhibitory Concentration 50Klebsiella pneumoniaePhenolsPlant LeavesAnti-Bacterial AgentsPhenolsPlant ExtractsTransforming Growth Factor beta1

Identifiers

PMID38655992
PMCPMC11042826
OpenAlexW4395466307

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.